Higher rates of triple‐class virological failure in perinatally HIV‐infected teenagers compared with heterosexually infected young adults in Europe

…, A Sönnerborg, R Teira, M Garrido… - HIV …, 2017 - Wiley Online Library
Objectives The aim of the study was to determine the time to, and risk factors for, triple‐class
virological failure ( TCVF ) across age groups for children and adolescents with perinatally …

Quasi-conjugate Bayes estimates for GPD parameters and application to heavy tails modelling

J Diebolt, MA El-Aroui, M Garrido, S Girard - Extremes, 2005 - Springer
We present a quasi-conjugate Bayes approach for estimating Generalized Pareto
Distribution (GPD) parameters, distribution tails and extreme quantiles within the Peaks-Over-…

Hepatitis C virus and human immunodeficiency virus coinfection in Spain

B Roca, I Suarez, J Gonzalez, M Garrido… - Journal of Infection, 2003 - Elsevier
Objective and methods: In a cross-sectional study, based on a cohort composed of HIV-infected
patients of fifteen tertiary level institutions of Spain, the main data of the entire cohort are …

Bacterial meningitis in HIV-1-infected patients in the era of highly active antiretroviral therapy

…, B Roca, J Gonzalez, F Lozano, M Garrido… - JAIDS Journal of …, 2009 - journals.lww.com
Background: The burden that spontaneous bacterial meningitis (SBM) currently represents
among HIV-1-infected patients is poorly known. Methods: We prospectively evaluated 32 …

Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg-and HIV-positive individuals: results from an inter-cohort analysis

…, M Rickenbach, I Suarez–Lozano, M Garrido… - Antiviral …, 2006 - journals.sagepub.com
Background The impact of lamivudine (3TC) as part of combination antiretroviral therapy (cART)
on the risk of liver-related death (LRD) in HIV/hepatitis B virus (HBV)-coinfected patients …

[HTML][HTML] Dyslipidemia and cardiovascular disease risk factor management in HIV-1-infected subjects treated with HAART in the Spanish VACH cohort

…, T Sánchez, F Torres, JR Lacalle, M Garrido - The open AIDS …, 2008 - ncbi.nlm.nih.gov
Background: There is increasing evidence that metabolic adverse effects associated with
antiretroviral therapy may translate into an increased cardiovascular risk in HIV-1-infected …

[HTML][HTML] Bayesian hierarchical models for disease mapping applied to contagious pathologies

S Coly, M Garrido, D Abrial, AF Yao - PloS One, 2021 - journals.plos.org
Disease mapping aims to determine the underlying disease risk from scattered epidemiological
data and to represent it on a smoothed colored map. This methodology is based on …

Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort)

I Suárez-Lozano, JM Fajardo, M Garrido, B Roca… - Aids, 2002 - journals.lww.com
This cohort study (VAHC cohort) was conducted to evaluate temporal changes of HIV
infection in Spain. The study enrolled 4335 HIV-positive patients. Results showed that the …

No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell …

…, C Torti, C Sabin, R Teira, M Garrido… - Journal of the …, 2021 - Wiley Online Library
Introduction Since the beginning of the HIV epidemic in resource‐rich countries,
Pneumocystis jirovecii pneumonia (PjP) is one of the most frequent opportunistic AIDS‐defining …

First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH …

…, T Sanchez, JR Lacalle, M Garrido - Journal of …, 2008 - academic.oup.com
Background Efavirenz and lopinavir/ritonavir are both recommended antiretroviral agents for
combination first-line therapy, although information on direct comparisons between them is …